CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,346,032 | +2.7% | 509,934 | 0.0% | 0.55% | -4.9% |
| Q1 2023 | $11,045,170 | +106544.5% | 509,934 | 0.0% | 0.58% | +5.9% |
| Q4 2022 | $10,357 | -99.9% | 509,934 | 0.0% | 0.54% | -28.6% |
| Q3 2022 | $13,075,000 | +7.8% | 509,934 | 0.0% | 0.76% | +19.2% |
| Q2 2022 | $12,126,000 | +36.0% | 509,934 | +28.8% | 0.64% | +45.2% |
| Q1 2022 | $8,919,000 | +13.7% | 396,029 | 0.0% | 0.44% | +18.0% |
| Q4 2021 | $7,841,000 | +0.6% | 396,029 | 0.0% | 0.37% | -11.4% |
| Q3 2021 | $7,794,000 | -10.5% | 396,029 | 0.0% | 0.42% | -19.0% |
| Q2 2021 | $8,713,000 | -45.1% | 396,029 | -40.6% | 0.52% | -53.9% |
| Q1 2021 | $15,860,000 | +53.1% | 666,682 | +68.3% | 1.13% | +25.1% |
| Q4 2020 | $10,360,000 | +50.3% | 396,029 | 0.0% | 0.90% | +28.3% |
| Q3 2020 | $6,893,000 | -38.7% | 396,029 | -40.7% | 0.70% | -43.7% |
| Q2 2020 | $11,236,000 | +41.5% | 668,020 | 0.0% | 1.25% | +15.8% |
| Q1 2020 | $7,943,000 | +10.2% | 668,020 | +12.1% | 1.08% | +27.9% |
| Q4 2019 | $7,210,000 | -14.4% | 595,828 | 0.0% | 0.84% | -24.2% |
| Q3 2019 | $8,422,000 | +26.8% | 595,828 | 0.0% | 1.11% | +13.5% |
| Q2 2019 | $6,643,000 | -5.0% | 595,828 | -0.0% | 0.98% | -15.4% |
| Q1 2019 | $6,995,000 | +2.2% | 595,834 | +16.3% | 1.16% | -12.3% |
| Q4 2018 | $6,843,000 | -5.1% | 512,169 | -0.4% | 1.32% | -1.0% |
| Q3 2018 | $7,211,000 | +4.0% | 514,303 | +16.6% | 1.33% | -6.7% |
| Q2 2018 | $6,934,000 | +104.0% | 441,103 | +113.5% | 1.43% | +76.3% |
| Q1 2018 | $3,399,000 | +38.3% | 206,620 | +51.8% | 0.81% | +32.3% |
| Q4 2017 | $2,458,000 | -3.6% | 136,120 | +3.0% | 0.61% | -26.0% |
| Q3 2017 | $2,550,000 | +61.1% | 132,108 | -1.6% | 0.83% | +38.0% |
| Q2 2017 | $1,583,000 | +9.4% | 134,191 | +1.6% | 0.60% | -4.6% |
| Q1 2017 | $1,447,000 | +71.2% | 132,020 | +13.4% | 0.63% | +44.3% |
| Q4 2016 | $845,000 | – | 116,424 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |